Drug Type Gene therapy |
Synonyms |
Target |
Action modulators |
Mechanism COL7A1 modulators(Collagen alpha-1(VII) chain modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (European Union) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epidermolysis Bullosa Dystrophica | Phase 2 | Ireland | 30 Jan 2022 |